BOOST BIOPHARMA
Live / Applied — Suspended — suspension check completed, case still suspended (as of 15 Dec 2025)
What this means for you
Not registered yet, but its 05 Jan 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97203987
- Mark type
- Stylized text
- Filed
- 05 Jan 2022
- Attorney of record
- Paul Sennott
Goods and services
- Class 001 — Chemicals: biological and chemical preparations, and substances, comprising nucleic acids and sequences thereof, amino acids and sequences thereof, peptides, proteins, or combinations of the forgoing, for the development of vaccines for scientific and medical purposes; Nucleic acids and proteins in raw material form for scientific and medical purposes
- Class 005 — Pharmaceuticals: vaccines, nucleic acid sequences and chemical reagents for medical and veterinary purposes, and protein arrays for medical diagnostic purposes; pharmaceutical and biological preparations and substances, comprising nucleic acids, amino acids, peptides, proteins, or combinations of these, for the diagnosis, prevention, and treatment of bacterial, viral, and parasitic infectious disease, and cancer, for use in connection with humans and animals; pharmaceutical and biological products, namely, diagnostic products, prophylactic products, therapeutic products, vaccines and antibodies for bacterial, viral, and parasitic infectious disease, and vaccines and antibodies for cancer, for use in connection with humans and animals for medical or veterinary purposes; diagnostic preparations for use in connection with humans and animals for medical or veterinary purposes; diagnostic products being diagnostic preparations for use in connection with humans and animals for medical or veterinary purposes
- Class 042 — Scientific and technological services: Medical and pharmaceutical research and development of vaccines, nucleic acids, and proteins for use in connection with humans and animals; Medical and pharmaceutical research and development of medical diagnostics for use in connection with humans and animals; Medical and pharmaceutical research and development of vaccine platform technologies; Medical and pharmaceutical research and development of proteins and nucleic acids; Medical and pharmaceutical research and development of medical diagnostics; biomedical research services; pharmaceutical and biological product development services; pharmaceutical and biological product development consulting
Owner
- Boost Biopharma, Inc., Wilmington, DE, US
Prosecution history
- 15 Dec 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 28 May 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 28 Nov 2024 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 22 Dec 2023 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 06 Dec 2023 — ASSIGNED TO EXAMINER
- 17 Apr 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 17 Apr 2023 — LETTER OF SUSPENSION E-MAILED
- 17 Apr 2023 — SUSPENSION LETTER WRITTEN
- 15 Apr 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Apr 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Apr 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Oct 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Oct 2022 — NON-FINAL ACTION E-MAILED
- 14 Oct 2022 — NON-FINAL ACTION WRITTEN
- 11 Oct 2022 — ASSIGNED TO EXAMINER